Parexel

Parexel is a global contract research organization (CRO) founded in 1982 and headquartered in Durham, North Carolina. With over 21,000 employees across more than 50 countries, Parexel specializes in helping pharmaceutical and biotechnology companies navigate the FDA regulatory approval process and offers a wide range of outsourced clinical research services. The company provides clinical research services, regulatory consulting, and market access strategy consulting. It has strong expertise in managing clinical trials, particularly in oncology and biotech sectors. Parexel also employs innovative approaches, such as decentralized clinical trials, to enhance patient diversity and accessibility. Additionally, the company integrates advanced technology and data analytics solutions to improve clinical trial efficiency and decision-making. Parexel serves a diverse clientele, including large pharmaceutical companies, emerging biotech firms, and medical device manufacturers. The company is recognized for its significant contributions to oncology and biotech clinical trials and has a strong presence in Asia, supporting global drug development initiatives.